Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPLF.L Regulatory News (MPLF)

  • There is currently no data for MPLF

Dividend Declaration

30 Mar 2021 07:00

RNS Number : 8770T
Marble Point Loan Financing Limited
30 March 2021
Β 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR IN THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN, OR ANY OTHER JURISDICTION, OR TO ANY PERSONS, WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAW.

Β 

30 March 2021

Β 

Β 

Marble Point Loan Financing Limited

Dividend Declaration

Β 

The Board of Directors of Marble Point Loan Financing Limited (the "Company") has declared a dividend in respect of the quarter ending 31 March 2021. The dividend will be payable to the Company's shareholders of record as detailed below:

Dividend:

$0.02 per ordinary share

Ex-Dividend Date:

08 April 2021

Record Date:

09 April 2021

Final Currency Election Date:

12 April 2021

Payment Date:

30 April 2021

The Company declares its cash dividends in U.S. Dollars. Shareholders will, by default, receive their cash dividends in U.S. Dollars. However, the Company has arranged for shareholders to be able to elect to receive cash dividends in Sterling rather than U.S. Dollars. Shareholders who have made an election to receive the dividend in Sterling by the above-referenced Final Currency Election Date will receive the dividend at the prevailing rate at time of currency conversion (as determined by the Company's registrar)[1]. No action is required of shareholders who have previously made a dividend currency election or who wish to receive their dividend in U.S. Dollars. The Sterling Dividend Election Information regarding the dividend currency election and Dividend Currency Election Form are available on the Company's website: www.mplflimited.com/investor-relations.

Past performance is not indicative, or a guarantee, of future performance.

This release contains inside information.

ENQUIRIES

Marble Point Loan Financing Limited

Investor Relations

Tel.: +44 (0) 20 7259 1500

Email: ir@mplflimited.com

Β 

Β 

Corporate Broker

Stifel Nicolaus Europe Limited

T: +44 (0) 20 7710 7600

Β 

Β 

Financial Public Relations:

Charlie Barker / Catherine Chapman

MHP Communications

T: +44 (0) 20 3128 8100

MarblePoint@mhpc.com

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

ABOUT MARBLE POINT LOAN FINANCING LIMITED

Marble Point Loan Financing Limited (the "Company") is a Guernsey closed-ended investment company with its ordinary shares admitted to trading on the Specialist Fund Segment of the Main Market of the London Stock Exchange (tickers: MPLF LN / MPLS LN). The Company is invested in a diversified portfolio of US dollar denominated, broadly syndicated floating rate senior secured corporate loans via CLOs, loan accumulation facilities and other vehicles managed by Marble Point Credit Management LLC or its affiliates. For more information, please visit the Company's website: www.mplflimited.com.

LEI: 549300DWXSN5UC85CL26

Β 

IMPORTANT INFORMATION

This document is provided for informational purposes only and does not constitute an offer to sell any shares, notes or other securities (collectively, "Securities") issued by the Company or a solicitation of an offer to purchase any such Securities in the United States, Australia, Canada, the Republic of South Africa, Japan or any other jurisdiction. This document may not be relied upon, and should not be used, for the purpose of making any investment decision. The Securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered or sold in the United States to, or for the account or benefit of, U.S. persons unless they are registered under applicable law or exempt from registration. The Company has not been and will not be registered under the U.S. Investment Company Act of 1940 and investors will not be entitled to the benefits of such Act.

Past performance is not a reliable indicator of current of future results. The value of investments may go down as well as up and investors may not get back any of the amount invested. The value of investments designated in another currency may rise and fall due to exchange rate fluctuations in respect of the relevant currencies. Adverse movements in currency exchange rates can result in a decrease in return and a loss of capital.

Β 

[1] The US Dollar to Sterling exchange rate may include a conversion spread of 1.5%.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DIVEAPDNASXFEFA
Date   Source Headline
21st Jul 20236:00 pmRNSDividend Declaration
20th Jul 20237:00 amRNSNet Asset Value & Publication of Monthly Report
29th Jun 20237:00 amRNSDividend Declaration
26th Jun 20236:02 pmRNS1st Quarter Results
23rd Jun 20235:30 pmRNSAnnouncement of Corporate Actions
23rd Jun 20237:00 amRNSNet Asset Value & Publication of Monthly Report
19th May 20231:36 pmRNSRevolving Credit Facility Extension
19th May 20237:00 amRNSNet Asset Value & Publication of Monthly Report
15th May 20234:31 pmRNSDistribution Announcement
24th Apr 20235:30 pmRNSSterling Dividend Amount
21st Apr 20235:00 pmRNSNet Asset Value & Publication of Monthly Report
12th Apr 20236:00 pmRNSAnnual Financial Report
11th Apr 20234:10 pmRNSHolding(s) in Company
30th Mar 20234:10 pmRNSDividend Declaration
23rd Mar 20237:00 amRNSNet Asset Value & Publication of Monthly Report
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Feb 20237:00 amRNSLiquidating Share Class Distribution Announcement
22nd Feb 20237:00 amRNSNet Asset Value & Publication of Monthly Report
30th Jan 20237:00 amRNSHolding(s) in Company
23rd Jan 20237:00 amRNSNet Asset Value & Publication of Monthly Report
19th Jan 20236:00 pmRNSDividend Declaration
12th Jan 20236:17 pmRNSMPLF Director / PDMR Shareholding
12th Jan 20236:00 pmRNSCompany Investment Manager Acquired by Investcorp
10th Jan 20236:00 pmRNSHolding(s) in Company
28th Dec 20226:00 pmRNSDividend Declaration
22nd Dec 20226:30 pmRNSNotice of Ordinary Share Re-designation
22nd Dec 20226:30 pmRNSChanges to the Board of Directors
21st Dec 20226:30 pmRNSNet Asset Value & Publication of Monthly Report
2nd Dec 20227:30 amRNSCompany Investment Manager Agrees to Combination
22nd Nov 20226:00 pmRNS3rd Quarter Results
22nd Nov 20227:00 amRNSNet Asset Value & Publication of Monthly Report
17th Nov 20227:00 amRNSResults of General Meeting
17th Nov 20227:00 amRNSResults of Annual General Meeting
26th Oct 20227:00 amRNSNotice of Annual General Meeting
25th Oct 20227:00 amRNSNet Asset Value & Publication of Monthly Report
21st Oct 20226:00 pmRNSSterling Dividend Amount
29th Sep 20227:00 amRNSDividend Declaration
21st Sep 20227:00 amRNSNet Asset Value & Publication of Monthly Report
13th Sep 20226:00 pmRNSHalf-Year Report
19th Aug 20227:00 amRNSNet Asset Value & Publication of Monthly Report
26th Jul 20227:00 amRNSIssue of Equity
22nd Jul 20226:30 pmRNSNet Asset Value & Publication of Monthly Report
21st Jul 20226:00 pmRNSDividend Declaration
15th Jul 20227:00 amRNSPublication of Key Investor Document
30th Jun 20227:00 amRNSDividend Declaration
23rd Jun 20227:00 amRNSNet Asset Value & Publication of Monthly Report
23rd Jun 20227:00 amRNSTotal Voting Rights
20th Jun 20227:00 amRNSDirector/PDMR Shareholding
16th Jun 20225:32 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.